Community Counts: Exploring Transcription Regulation & Immunotherapy for ES-SCLC: Tweetorial #1 Evaluation (ID: i805-4) Survey

1.How many years have you been in practice?(Required.)

>21

11-20

1-10

<1

2.How many patients with ES-SCLC do you manage per week?(Required.)

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

3.Please select the option that best describes your practice setting.(Required.)

4.After participating in this activity, how confident are you in the management of patients with ES-SCLC in your practice? (Required.)

5.How committed are you to making changes in your practice based on your participation in this activity?(Required.)

If not committed or do not plan to make changes, please indicate reason

6.Which of the following best describes the impact of this activity on your performance?(Required.)

I gained new strategies/skills/information I can apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

7.Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.(Required.)

Have a better understanding of patient subsets in which pembrolizumab and nivolumab are most beneficial

Carefully select patients for treatment with pembrolizumab and nivolumab

Consider PD-L1 testing in patients eligible for third-line therapy

Review of trial results prior to treatment selection

Review of guideline recommendation prior to treatment selection

Other (please specify)

8.What barriers do you see to making changes in your practice? Please select all that apply.  (Required.)

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please specify)

13.As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

14.Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for ES-SCLC:

15.If you indicated that you perceived commercial bias or influence, please describe: